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Condyloma acuminata is caused by the proliferation of squamous epithelial cells in the presence of
human papilloma virus (HPV) infection. There are several treatment options available for anogenital
warts, however, none have proven to be more efﬁcacious. We present the case of a 3 year-8 months-old
male, diagnosed with human immunodeﬁciency virus (HIV) infection, who presented with multiple
warts in the anogenital region. Lesions were treated with imiquimod 5%, electrosurgical resection and
interferon a-2b. Combination of electrofulguration and interferon a-2b is an effective treatment option
for children with giant condyloma accuminatum although recurrence is expected within a short follow-
up period.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The Buschke-Löwenstein tumor (BLT), or giant condyloma acu-
minatum, is a semi-malignant verrucous neoplasia characterized by
aggressive growth into underlying dermal structures. It is recurrent
in 30e70% of cases and can progress slowly into exophytic, ulcer-
ative and cauliﬂower-shaped tumors that can form abscesses and
ﬁstulas.1,2 It is generally located on the genital area, however, on
occasions it involves distinct histological zones of the anorectal
region.1 Now a days there is no approved treatment by the Food and
Drug Administration in the pediatric population, nevertheless a
number of treatment options are available for anogenital warts.3 In
2010 the Center for Disease Control and Prevention published its
guidelines on sexually transmitted diseases and recommended that
treatment be directed based on size, location and number of lesions.
The therapeutic options include topical ointments, cryotherapy,
laser vaporization, electrosurgery and surgical excision. The aim ofEspecialidad de la Península
Merida Yucatán, Mexico.
ze).
Inc. This is an open access article utreatment is to eliminate visible warts, nonetheless that does not
guarantee eradication of HPV infection.3Case report
A 3 year-8 months-old male presented to the emergency
departmentwith a large cauliﬂower-like growth covering the penis,
scrotum, perineal and perianal region. The patient was tested HIV
ELISA positive as a consequence of vertical transmission from his
20-year-old mother, also HIV positive. The mother’s HPV infection
was never documented since she abandoned the patient after their
ﬁrst hospital visit. No history or evidence of sexual abuse of the
child was encountered. A ﬁnal diagnosis of pediatric HIV presenting
with giant genital and perianal condyloma acuminatawasmade. He
was initiated on broad-spectrum antibiotics and antirretroviral
therapy with lopinavir, ritonavir, abacavir and lamivudin.
The growth had started 2 years prior as warty lesions around the
genital area, and had increased in size and coalesced to assume
large dimensions invading the scrotum, base of the penis, prepuce,
perineal area and anal sphincter. At presentation to the emergency
department in January 2015, the HIV viral load was undetectable,
and a CD4 percentage of 23% (range: 31e60%) was reported (Fig. 1).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Initial presentation. Figure 2. Postoperative picture after fourth surgery (3 months after treatment).
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three times per week without any visible improvement. Therefore,
electrosurgical resection was performed under general anesthesia
over multiple sessions due to the considerably large size of the
condyloma. Complete resection was achieved after seven in-
terventions separated by 2-week intervals. The specimens were
sent for histopathological evaluations, and condyloma acuminata
with neovascular proliferation was reported. No serotype assess-
ment was made due to test unavailability at our institution. After
completion of electrosurgical treatment, immunotherapy was
initiatedwith IFN a2b at a dosage of 2million units per week during
4 weeks (Figs. 2 and 3).
Monthly outpatient follow-up was scheduled for a year. Recur-
rence in the genital area was documented 3 months following
complete resection of the lesion. Cutaneous examination of the
perianal region showed no remaining scrotal skin per-se, instead,
the area showed reddish-brown plaques with soft non-ﬁbrotic
tissue. No further alterations were observed on the penis, anus or
urethra.
An additional 0.5 cm recurrence in the perianal zone was
noticed on the 12th month of consultation, and ophthalmologists
were requested to assess a solitary papillary lesion on the caruncle
and tarsal conjunctiva of the right eye, originally treated with an
unsuccessful cycle of IFN a2b. The patient is now awaiting surgery
for both lesions.
Discussion
The Buschke-Löwenstein tumor is a rare entity with an average
incidence of 0.1% in the general population.4 Infection by HPV has
been linked to the development of BLT and recently 70 subtypeshave been reported.1 The HPV is classiﬁed as high and low-grade,
depending on the virus oncogenic potential. The low-grade sub-
types include 6, 11, 42, 43 and 44; and are isolated from 90% of
genital warts.3 The high-grade subtypes 16, 18, 31, 33, 35 and 45 are
capable of causing high-grade dysplasia and squamous cell carci-
noma. The presence of co-infection by high-grade HPV in genital
warts is 31%.3 The immune system effectively repels the majority of
HPV infections by localized cell-mediated immune responses.
Approximately, 10% of individuals will develop a persistent infec-
tion with a risk of proliferative lesions, high-grade precursors and
eventually an invasive carcinoma. In our reported case, it was not
possible to determine the subtype of the virus.
In the pediatric population the average age to develop anorectal
warts has been reported to be between 2.8 and 5.6 years of age.5
The proposed mechanism for perinatal and postnatal trans-
mission includes vertical transmission, autoinoculation, sexual
transmission and indirectly through contaminated objects and
surfaces. The incubation period varies between 3 weeks and
8 months and the majority of anogenital warts appear 2e3 months
after exposure. The rates of vertical transmission of HPV to the
neonate in women without clinical evidence of infection varies
between 1e18%, compared to 5e72% in women with a detectable
HPV infection during pregnancy.5 Co-infection with HPV occurs in
8e10% of HIV positive pediatric patients.
Treatment is difﬁcult due to the high recurrence rates (30e70%)
and risk of bleeding.1 There are a number of medical and surgical
treatment options available to treat anogenital condyloma
acuminata.
Surgical management consists of excision, fulguration or both.
Without a current gold-standard, surgery remains the cornerstone
of treatment. The case reports that have been published show
Figure 3. Last follow-up picture after eighth surgery (8 months after treatment).
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with mono or combined therapy. However, they are not mutually
comparable, and neither has any superior efﬁcacy over the other
that can be sustained.
The case presented is of particular interest due to the extent of
the lesions and their rapid appearance, associated with a low HIV
load in response to the administration of antiretrovirals. Also of
interest is the refractoriness shown by the condylomas to topical
therapy with imiquimod, not only did they not diminish but ratherincreased in size and number. These observations suggest a possible
synergistic adverse effect of HIV for the control of human papilloma
virus infection. However, the subsequent handling of a combined
scheme with IFN and electrosurgical resection was successful for
the complete elimination of the condyloma acuminata. Although
the behavior of HPV remained unchanged, a rapid recurrence of
lesions merited new surgical events. This unusual behavior, even
considering the rate of recurrence high in the general population, is
likely due to the combination of viral diseases. This should be kept
in mind in the regular and frequent clinical monitoring of the pa-
tient despite having a good control of viral replication expressed by
a low HIV load.
Conclusion
The Buschke-Löwenstein tumor or giant condyloma acumina-
tum is an extremely rare clinical type of genital wart in the pediatric
population, with a high recurrence rate whichmay be higher due to
the synergistic effect of HIV on HPV’s aggressive nature. HIV
infection should thus be considered an additional risk factor for a
poor response to medical treatment only, with a high risk of
recurrence. Electrosurgical resection and IFN therapy are efﬁcacious
procedures to control the rapid extension of the disease.
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